In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

[1]  Troy Guthrie,et al.  Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  George E. Katibah,et al.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. , 2015, Cell reports.

[3]  S. Shafti-Keramat,et al.  A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types , 2015, PloS one.

[4]  E. Furth,et al.  Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma , 2015, Cancer Immunology Research.

[5]  J. Wolchok,et al.  CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic , 2014, Front. Oncol..

[6]  A. Rynda-Apple,et al.  Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung. , 2014, Nanomedicine.

[7]  P. Lizotte,et al.  Stimulating antitumor immunity with nanoparticles. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[8]  P. Lizotte,et al.  Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis , 2014, Oncoimmunology.

[9]  I. Adcock,et al.  Cytokine inhibition in the treatment of COPD , 2014, International journal of chronic obstructive pulmonary disease.

[10]  David J Mooney,et al.  Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants. , 2014, Cancer research.

[11]  A. Rynda-Apple,et al.  CD11c+ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice , 2014, European journal of immunology.

[12]  P. Savard,et al.  This information is current as Infection Listeria Monocytogenes Protection from Mediated − T Cell + Enhances CD 8 Nanoparticle Adjuvant Sensing by TLR 7 , 2013 .

[13]  N. Steinmetz,et al.  Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[14]  C. Slingluff,et al.  Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T Cells , 2013, Cancer Immunology Research.

[15]  P. Darcy,et al.  Gene-engineered T cells for cancer therapy , 2013, Nature Reviews Cancer.

[16]  P. Lizotte,et al.  Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. , 2013, Cancer research.

[17]  A. Rynda-Apple,et al.  Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza. , 2013, ACS nano.

[18]  Meng-Lei Zhu,et al.  Aire deficiency promotes TRP-1-specific immune rejection of melanoma. , 2013, Cancer research.

[19]  Alaa A. A. Aljabali,et al.  CPMV-DOX delivers. , 2013, Molecular pharmaceutics.

[20]  P. Lizotte,et al.  Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge , 2013, The Journal of Immunology.

[21]  M. Bachmann,et al.  Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen , 2012, The Journal of Immunology.

[22]  J. Langley,et al.  Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age. , 2012, Vaccine.

[23]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[24]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[25]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[26]  B. Berwin,et al.  IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer , 2011, Front. Immun..

[27]  Axel Hoos,et al.  Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. , 2011, The New England journal of medicine.

[28]  N. Steinmetz,et al.  Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. , 2011, Nanomedicine.

[29]  A. Satelli,et al.  Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.

[30]  Xiao‐Yu Yin,et al.  Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. , 2011, Journal of hepatology.

[31]  Charlotte E. Egan,et al.  Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. , 2011, International immunology.

[32]  G. Pizzolo,et al.  Neutrophil activation and survival are modulated by interaction with NK cells. , 2010, International immunology.

[33]  S. Weiss,et al.  Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. , 2010, The Journal of clinical investigation.

[34]  L. Cosmi,et al.  Evidence for a cross-talk between human neutrophils and Th17 cells. , 2010, Blood.

[35]  Chris S. Rae,et al.  Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo , 2009, PloS one.

[36]  G. Lomonossoff,et al.  Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants. , 2009, Virology.

[37]  T. Douglas,et al.  Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses , 2009, PloS one.

[38]  C. Ahonen,et al.  In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. , 2009, Cancer research.

[39]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[40]  V. Barnaba,et al.  Neutrophils efficiently cross-prime naive T cells in vivo. , 2007, Blood.

[41]  T. Geijtenbeek,et al.  Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN , 2005, The Journal of experimental medicine.

[42]  Lin Zhang,et al.  Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A , 2004, Nature Medicine.

[43]  B. Milleron,et al.  Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. , 2003, Cancer research.

[44]  H. Schreiber,et al.  Inhibition of tumor growth by elimination of granulocytes , 1995, The Journal of experimental medicine.

[45]  G. Bruening,et al.  Two proteins from cowpea mosaic virus. , 1971, Virology.

[46]  G. Lomonossoff,et al.  Genetic engineering and characterization of Cowpea mosaic virus empty virus-like particles. , 2014, Methods in molecular biology.

[47]  A. Rynda-Apple,et al.  Immunopathology and Infectious Diseases Virus-Like Particle-Induced Protection Against MRSA Pneumonia Is Dependent on IL-13 and Enhancement of Phagocyte Function , 2012 .